Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Rethinking the Enterprise
The first 'essential business read' of 2010 World's Leading CEOs provide key insights for business success in the new economic environment. More than twelve hundred of the world's senior business executives, CEOs and public sector leaders have candidly contributed their latest insights and opinions to a new book, Rethinking the Enterprise: Insights from the World's Leading CEOs. Rethinking the Enterprise is the first essential text for all business leaders to consider as 2010 begins and the economy regains momentum. The book starts by setting out the findings of IBM's third biennial Global CEO Study which draws on in-depth conversations with 1200+ business leaders, who represent a diverse ra...
Sarcoidosis
Recent reports indicate that the prevalence of sarcoidosis is rising and mortality in chronic sarcoidosis patients is increasing. With myriad clinical manifestations, and multi-system involvement, there is a need for all clinicians to have a working knowledge of the condition. This Monograph provides a comprehensive overview of the most recent advances in sarcoidosis. Opening with chapters on history, epidemiology and pathobiology, it goes on to provide in-depth coverage of: specific organ manifestations and general diagnostic pathways; traditional as well as innovative treatment strategies; and, importantly, patient quality-of-life assessment. This book will be useful to clinicians around the world.
Immune Landscape of Kidney Pathology
Topic Editor Dr. Patrick Tang holds patents related to anticancer therapy and diabetic prevention. All other Topic Editors declare no competing interests with regards to the Research Topic.
Pulmonary Hypertension: Mechanisms and Management, History and Future
We are grateful for the support of Actelion – a sponsor of this Research Topic – whose cooperation has contributed to fostering scientific discovery by reducing article publishing costs for some authors. We hereby state publicly that Actelion has had no editorial input in articles included in this research topic, thus ensuring that all aspects of this Research Topic were evaluated objectively, unbiased by any specific policy or opinion of Actelion. Actelion is part of the Johnson & Johnson Family of Companies. We are leaders in the science and medicine of pulmonary arterial hypertension (PAH), with over 15 years of experience in this devastating cardiovascular disorder.
